Your Health, We Care
Cabergoline is an ergot derivative indicated for the treatment of hyperprolactinemic disorders in adults, whether idiopathic or caused by pituitary adenomas.
Usage Limitation: Avoid using cabergoline to suppress or terminate physiological lactation after childbirth, due to the risk of serious adverse reactions.
FDA，2025.04
It is indicated for the treatment of hyperprolactinemia in adults, including con···【more】
Release date：2026-01-05Recommended：0
